Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 15, 2014 - Issue 6
Submit an article Journal homepage
632
Views
8
CrossRef citations to date
0
Altmetric
Drug Evaluations

Mirabegron in the treatment of overactive bladder

Umberto Leone Roberti MaggioreIRRCS San Raffaele Hospital and Vita-Salute San Raffaele University, Via Olgettina 58-60, 20132, Milan, Italy
, MD,
Linda CardozoKing's College Hospital, Department of Urogynaecology, Denmark Hill, London, SE5 9RS, UK
, MD,
Simone FerreroUniversity of Genoa, San Martino Hospital and National Institute for Cancer Research, Department of Obstetrics and Gynecology, Largo R. Benzi 1, 16132, Genoa, Italy+ 01139 010511525; + 01139 010511525; [email protected]
, PhD,
Filomena SileoIRRCS San Raffaele Hospital and Vita-Salute San Raffaele University, Via Olgettina 58-60, 20132, Milan, Italy
, MD,
Alice ColaIRRCS San Raffaele Hospital and Vita-Salute San Raffaele University, Via Olgettina 58-60, 20132, Milan, Italy
,
Marco TorellaChild and of General and Specialized Surgery Second University of Studies of Naples, Department of Woman, 80138 Naples, Italy
, MD,
Nicola ColacurciChild and of General and Specialized Surgery Second University of Studies of Naples, Department of Woman, 80138 Naples, Italy
, MD,
Massimo CandianiIRRCS San Raffaele Hospital and Vita-Salute San Raffaele University, Via Olgettina 58-60, 20132, Milan, Italy
, MD &
Stefano SalvatoreIRRCS San Raffaele Hospital and Vita-Salute San Raffaele University, Via Olgettina 58-60, 20132, Milan, Italy
, MD show all
Pages 873-887 | Published online: 19 Mar 2014

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Vojtech Hainer. (2016) Beta3-adrenoreceptor agonist mirabegron – a potential antiobesity drug?. Expert Opinion on Pharmacotherapy 17:16, pages 2125-2127.
Read now

Articles from other publishers (7)

Serkan Karakus, Biljana Musicki & Arthur L. Burnett. (2021) Mirabegron improves erectile function in men with overactive bladder and erectile dysfunction: a 12-week pilot study. International Journal of Impotence Research 34:6, pages 588-592.
Crossref
Tom Marcelissen, Tina Rashid, Tiago Antunes Lopes, Nicolas Barry Delongchamps, Bogdan Geavlete, Malte Rieken, Jean-Nicolas Cornu & Mohammad Sajjad Rahnama'i. (2019) Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand?. European Urology Focus 5:6, pages 1112-1119.
Crossref
Anka J Nieuwhof-Leppink, Rogier P J Schroeder, Elise M van de Putte, Tom P V M de Jong & Renske Schappin. (2019) Daytime urinary incontinence in children and adolescents. The Lancet Child & Adolescent Health 3:7, pages 492-501.
Crossref
Ricardo Palmerola & Victor Nitti. 2019. Contemporary Pharmacotherapy of Overactive Bladder. Contemporary Pharmacotherapy of Overactive Bladder 291 314 .
Maurizio Serati, Umberto Leone Roberti Maggiore, Paola Sorice, Simona Cantaluppi, Enrico Finazzi Agrò & Fabio Ghezzi. (2016) Is mirabegron equally as effective when used as first- or second-line therapy in women with overactive bladder?. International Urogynecology Journal 28:7, pages 1033-1039.
Crossref
Christina B. Ching. (2016) Current Treatment Options for Nonneurogenic Overactive Bladder in Children. Current Bladder Dysfunction Reports 11:1, pages 29-37.
Crossref
Ganesh Thiagamoorthy, Stephanie Kotes, Martino Zacchè & Linda Cardozo. (2015) The efficacy and tolerability of mirabegron, a β3 adrenoceptor agonist, in patients with symptoms of overactive bladder. Therapeutic Advances in Urology 8:1, pages 38-46.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.